Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 11.82B | 11.09B | 10.80B | 10.54B | 9.97B |
Gross Profit | 6.08B | 5.71B | 5.45B | 5.23B | 4.68B |
EBITDA | 4.21B | 3.80B | 3.64B | 3.53B | 3.06B |
Net Income | 2.19B | 1.86B | 1.76B | 1.73B | 1.46B |
Balance Sheet | |||||
Total Assets | 17.08B | 16.71B | 14.74B | 14.36B | 13.12B |
Cash, Cash Equivalents and Short-Term Investments | 4.53B | 6.95B | 6.27B | 5.17B | 6.22B |
Total Debt | 1.81B | 1.81B | 1.95B | 2.40B | 2.30B |
Total Liabilities | 4.21B | 4.48B | 4.16B | 4.62B | 4.33B |
Stockholders Equity | 12.87B | 12.23B | 10.58B | 9.74B | 8.79B |
Cash Flow | |||||
Free Cash Flow | 2.70B | 2.76B | 2.55B | 2.72B | 1.93B |
Operating Cash Flow | 2.84B | 2.98B | 2.61B | 2.90B | 2.33B |
Investing Cash Flow | -2.45B | -553.00M | 222.00M | -2.26B | -377.00M |
Financing Cash Flow | -2.82B | -1.75B | -1.74B | -1.69B | -1.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥44.90B | 9.07 | 3.61% | -9.58% | 13.22% | ||
77 Outperform | ¥36.43B | 15.71 | 2.85% | 6.71% | 26.33% | ||
75 Outperform | ¥40.66B | 6.19 | 1.96% | 12.06% | -45.04% | ||
71 Outperform | ¥12.08B | 8.13 | 3.66% | 2.12% | -6.76% | ||
71 Outperform | ¥10.85B | 8.48 | 3.99% | 6.95% | 4.92% | ||
64 Neutral | $10.61B | 16.56 | 6.55% | 2.15% | 2.87% | -30.79% | |
63 Neutral | ¥32.29B | 17.03 | 3.35% | 11.34% | 15.91% |
CTS Co., Ltd. reported a positive financial performance for the three months ended June 30, 2025, with net sales increasing by 6.5% and profit attributable to owners rising by 37.8% compared to the previous year. The company also announced a forecast for the fiscal year ending March 31, 2026, with anticipated growth in net sales and profits, indicating a strong market position and potential positive implications for stakeholders.